Education
About Us
Working with TipRanks
Follow Us
John Gordon Freund Insider Profile
4 Followers
John Gordon Freund, Director at Protara Therapeutics, holds 114.07K shares in Collegium Pharmaceutical (Ticker: COLL), holds 147.20K shares in SI-Bone (Ticker: SIBN), holds 56.33K shares in Sutro Biopharma (Ticker: STRO).
John Gordon Freund Protara Therapeutics (TARA)Director
Protara Therapeutics (TARA)
Director
Ranked #9,845 out of 102,596 Corporate Insiders
Profitable Transactions
12 out of 21 Profitable Transactions
Average Return
+11.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Gordon Freund holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 12, 2019 - Nov 12, 2020
Return:+90.90%
The most profitable trade made by John Gordon Freund
John Gordon Freund's Trading History
Protara Therapeutics
Nov 12, 2019
Director
Informative Buy
696.55K
$7.27M
Sutro Biopharma
Dec 14, 2020
Director
Uninformative Buy
―
$51.54K
SI-Bone
Jun 06, 2025
Director
Uninformative Buy
―
$2.56M
XenoPort
Jul 06, 2016
―
Uninformative Sell
3.92M
$3.91M
Tetraphase
Dec 12, 2019
―
Informative Sell
32.92K
$0.00
Collegium Pharmaceutical
Jun 11, 2025
Director
Uninformative Buy
201.75K
$3.66M
Concert Pharma
Feb 21, 2014
―
Uninformative Buy
―
$10.12M
Hansen Medical
Apr 21, 2009
―
Informative Buy
480.77B
$7.94M
Mako Surgical
―
―
―
―
Map Pharmaceuticals
―
―
―
―
List of latest transactions for each holding click on a transaction to see John Gordon Freund's performance on stock
You May Also Like
John Gordon Freund insider profile FAQ
What is the percentage of profitable transactions made by John Gordon Freund?
The percentage of profitable transactions made by John Gordon Freund is 57%.
What is the average return per transaction made by John Gordon Freund?
The average return per transaction made by John Gordon Freund is 11.00%.
What stocks does John Gordon Freund hold?
John Gordon Freund holds: TARA, STRO, SIBN, XNPT, TTPH, COLL, CNCE, HNSN, MAKO, ~MAPP stocks.
What was John Gordon Freund’s latest transaction?
John Gordon Freund latest transaction was an Uninformative Buy of $201.75K.
What was John Gordon Freund's most profitable transaction?
John Gordon Freund’s most profitable transaction was an Informative Buy of TARA stock on November 12, 2019. The return on the trade was 90.90%.
What is John Gordon Freund's role in Protara Therapeutics?
John Gordon Freund's role in Protara Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.